Zealand Pharma A/S
ZLDPF
$46.38
-$1.27-2.66%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 13,039.55% | -51.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13,039.55% | -51.40% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 13,039.55% | -51.40% | |||
| SG&A Expenses | 10.95% | 11.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.72% | -9.23% | |||
| Operating Income | 812.21% | 3.97% | |||
| Income Before Tax | 1,111.43% | 4.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1,088.95% | -2.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,088.95% | -2.38% | |||
| EBIT | 812.21% | 3.97% | |||
| EBITDA | 827.36% | 5.33% | |||
| EPS Basic | 1,092.62% | -2.01% | |||
| Normalized Basic EPS | 1,156.44% | 20.01% | |||
| EPS Diluted | 1,086.57% | -2.01% | |||
| Normalized Diluted EPS | 1,149.99% | 20.01% | |||
| Average Basic Shares Outstanding | -0.37% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.24% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||